http://www.onclive.com/sap-partner/cancer-centers/jtcc/john-theurer-cancer-center-researchers-share-46-cutting-edge-studies-at-2017-ash-meeting
John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH Meeting


Researchers from the Hackensack Merdian Health John Theurer Cancer Center at Hackensack University Medical Center will present results from 46 cancer-related studies during the American Society of Hematology (ASH) 59th Annual Meeting, which will take place December 9 – 12, 2017 in Atlanta. The studies examine new cancer treatments, ways to predict the best treatment outcomes, and patient quality of life issues.

“ASH is a great venue for sharing best practices and learning about the latest treatment approaches – we are proud to help contribute by presenting our recent scientific work,” André Goy, MD, MS, chairman and director, division chief of Lymphoma, John Theurer Cancer Center; chief science officer and director of Research and Innovation, RCCA; professor of medicine, Georgetown University. “Our researchers will keep working to improve oncology and help develop some of the newest approaches to treating cancer. This will remain a priority for our cancer center.” Among other promising research, John Theurer Cancer Center investigators will present highlights from studies in mantle cell lymphoma (MCL), stem cell transplantation, CAR T-cell therapy, precision medicine in multiple myeloma (MM), Hodgkin lymphoma and new combinations in blood cancers at the ASH annual meeting.

Novel strategies in mantle cell lymphoma
Novel strategies in stem cell transplantation
CAR T-cell therapy
Precision medicine in multiple myeloma
Novel therapies and new combinations in Hodgkin Lymphoma
Other novel therapies and new combinations in blood cancers
“Our research presented at this conference would not have been possible without the patients who participate in our clinical trials,” said Andrew L. Pecora, M.D., F.A.C.P., C.P.E., chief innovation officer, professor and vice president of cancer services, John Theurer Cancer Center. “We are thankful to our patients, our researchers, and our partnering institutions who help us bring novel therapies and improved regimens for cancer patients.”

For more information about the ASH conference or the research being presented, go to www.hematology.org/Annual-Meeting/.
Printer Printing...